The latest research into the link between germs and mental illness -- and what we all need to know.
Guest Host: Steve Roberts
A new study suggests antidepressants may be no more effective than placebo in all but severe cases of depression. A look at how drug effectiveness is measured and weighed against safety concerns in and beyond the drug approval process.
- Gardiner Harris science reporter for "The New York Times"
- Dr. William Potter serves on the FDA's Psychopharmacologic Drugs Advisory Committee, vice president for translational neuroscience at Merck Research Laboratories; board-certified psychiatrist
- Dr. Jerry Avorn Professor of Medicine at Harvard Medical School; Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital; author "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
- Blair Johnson professor of psychology, University of Connecticut; coauthor on new antidepressant study
Most Recent Shows
The country's 9-1-1 emergency call system was designed for landline telephones. With the growing reliance on mobile technology, experts say it’s out of date. Current gaps in the 9-1-1 system and how it can be improved.
Frank Sinatra was one of the top entertainers of the 20th century. A new biography on the many sides of "Ol Blue Eyes" – his singing career, Rat Pack exploits and legacy in American culture.
The attacks in Mali and Paris point to a broadening battlefield in a war being waged by disparate jihadist groups. The growth of Islamic extremism and the outlook for an international coalition to combat it.